i would almost guarantee that SLA's sp will slide if there is a prolonged period of a lack of news.
the market cap is in blue sky territory for something that "might" be a world class drug.
remember, virtually no biotech's successfully get a drug/and or treatment to market without a long period of trials and almost inevitable hiccups.
in comparison to a stock like cmp that has revenues, is already profitable, real earnings growth prospects in the short term & a market cap of roughly 1/7th the size of SLA the huge risks in SLA are obvious.
SLA Price at posting:
0.0¢ Sentiment: Sell Disclosure: Not Held